| Heska sells veterinary and animal health diagnostic and specialty products. Co.'s primary focus is on the canine and feline healthcare space. Co.'s business is composed of two segments: North America and International. Co.'s main product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production. We show 47 historical shares outstanding datapoints in our HSKA shares outstanding history coverage, used to compute HSKA market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing HSKA market cap history over the course of time is important for investors
interested in comparing HSKA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of HSKA versus a peer is one thing; comparing
HSKA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like HSKA can fluctuate over the course of history.
With this page we aim to empower investors researching HSKA by allowing them to research the HSKA market cap history.